Benefits and Limitations of Real-World Patient-Reported Toxicity Symptom Monitoring for Guidelines and Care, as Perceived by Patients, Clinicians, and Guideline Developers.
Saved in:
| Title: | Benefits and Limitations of Real-World Patient-Reported Toxicity Symptom Monitoring for Guidelines and Care, as Perceived by Patients, Clinicians, and Guideline Developers. |
|---|---|
| Authors: | Smit Y; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., Verweij L; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., Currie A; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., Janssen JJWM; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, the Netherlands., Dekker A; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre, the Netherlands., Hermens RPMG; Department of IQ Healthcare, Radboud University Medical Center, Nijmegen, the Netherlands., Blijlevens NMA; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands. |
| Source: | Cancer medicine [Cancer Med] 2025 Apr; Vol. 14 (8), pp. e70880. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2045-7634 |
|---|---|
| DOI: | 10.1002/cam4.70880 |
